| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |